Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Actavis Completes Acquisition of Allergan

March 18, 2015 9:09 am | News | Comments

The deal is valued at approximately $70.5 billion.


Potential Drug Target Found to Prevent Bowel Cancer Spread

March 18, 2015 9:03 am | by Monash University | News | Comments

Scientists have discovered a molecule that is crucial to the survival of stem cells in the intestine. Read more...


Roche Launches Next-Generation Duplex Test for Parovirus B19, Hepatitis A

March 18, 2015 8:56 am | News | Comments

This test is only available in markets accepting the CE mark. Read more...


Emerging Diseases Likely to be More Harmful in Similar Species

March 18, 2015 8:49 am | by University of Cambridge | News | Comments

Research shows that it may be possible to predict the virulence of a virus by looking at how deadly it is in closely-related species. Read more...


New Hope for Kidney Disease

March 18, 2015 8:43 am | by Monash University | News | Comments

Researchers have made a discovery that could see patients with kidney disease no longer having to resort to dialysis or kidney transplants. Read more...


Study: Euthanasia Cases More Than Double in Northern Belgium

March 18, 2015 8:40 am | by Raf Casert, Associated Press | News | Comments

Almost one in 20 people in northern Belgium died using euthanasia in 2013, more than doubling the numbers in six years. Read more...


Prices of Cancer Drugs Have Soared Since 1995: Study

March 17, 2015 12:43 pm | by Peter Dizikes, MIT News | News | Comments

The prices of leading cancer drugs have risen at rates far outstripping inflation over the last two decades, according to a new study co-authored by an MIT economist — but the exact reasons for the cost increases are unclear. Read more...


U.S. Pharmaceutical Market Value Will Approach $550 Billion by 2020: GlobalData

March 17, 2015 12:31 pm | News | Comments

The U.S. pharmaceutical market is forecast to increase from an estimated value of $395.2 billion in 2014 to reach $548.4 billion by 2020, representing a Compound Annual Growth Rate (CAGR) of 5.6 percent, according to research and consulting firm GlobalData. Read more..


Mississippi Wants Execution-Drug Supplier's Name Kept Secret

March 17, 2015 12:25 pm | by Jeff Amy - Associated Press | News | Comments

Mississippi's attorney general is asking a judge to keep the identity of the state's execution-drug supplier secret while he appeals her order to release the name. Read more....


23andMe FDA Approval Clears Way for More Sequencing-Based Tests

March 17, 2015 12:17 pm | News | Comments

​Kalorama information suggests that the FDA approval of a rare gene test from Mountain View, Calif.-based personal genetics company 23andMe will open the way for more genetic tests sold to consumers or prescribed by doctors that use next-generation sequencing technology. Read more...


Potential Treatment for Most Common Form of Muscular Dystrophy

March 17, 2015 12:02 pm | by University of Virginia Health System | News | Comments

A doctor who was one of the discoverers of the gene responsible for myotonic muscular dystrophy has now identified a therapeutic that could slow progression of muscle damage and muscle dysfunction associated with the disease – issues that cause patients significant disability and deterioration in quality of life. Read more...


Gene Discovery Provides Clue to How TB May Evade the Immune System

March 17, 2015 9:01 am | by University of Cambridge | News | Comments

The largest genetic study of tuberculosis susceptibility to date has led to a potentially important new insight into how the pathogen manages to evade the immune system. Read more...


New System Made for Detecting Adverse Effects of Medications Using Social Media

March 17, 2015 8:55 am | by Universidad Carlos III de Madrid | News | Comments

Researchers have developed a system for detecting adverse effects of pharmaceutical drugs by tracking information generated by patients on specialized blogs or social networks such as Twitter in real time. Read more...


GSK Announces Start of Phase 3 Program for Retosiban Evaluation

March 17, 2015 8:46 am | News | Comments

Retosiban is an investigational oxytocin antagonist.


American Who Contracted Ebola Now in Critical Condition

March 17, 2015 8:41 am | by Brett Zongker, Associated Press | News | Comments

An American health care worker who contracted Ebola while volunteering in a Sierra Leone treatment unit has been downgraded to critical condition at the National Institutes of Health, doctors said Monday. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.